[1] Tjuvajev JG, Avril N, Oku T, et al. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography[J]. Cancer Res, 1998, 58(19):4333-4341.
[2] Blasberg R. PET imaging of gene expression[J]. Eur J Cancer, 2002,38(16):2137-2146.
[3] Blasberg RG, Tjuvajev JG. Molecular-genetic imaging:current and future perspectives[J]. J Clin Invest, 2003, 111(11):1620-1629.
[4] Bengel FM, Anton M, Richter T, et al. Noninvasive imaging of transgene expression by use of positron emission tomography in a pig model of myocardial gene transfer[J]. Circulation, 2003, 108(17):2127-2133.
[5] Simoes MV, Miyagawa M, Reder S, et al. Myocardial kinetics of reporter probe 124I-FIAU in isolated perfused rat hearts after in vivo adenoviral transfer of herpes simplex virus type 1 thymidine kinase reporter gene[J]. J Nucl Med, 2005, 46(1):98-105.
[6] Ponde DE, Dence CS, Schuster DP, et al. Rapid and reproducible radiosynthesis of [18F] FHBG[J]. Nucl Med Biol, 2004, 31(1):133-138.
[7] Miyagawa M, Anton M, Haubner R, et al. PET of cardiac transgene expression:comparison of 2 approaches based on herpesviral thymidine kinase reporter gene[J]. J Nucl Med, 2004, 45(11):1917-1923.
[8] Jucaite A, Fernell E, Halldin C, et al. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder:association between striatal dopamine markers and motor hyperactivity[J]. Biol Psychiatry, 2005, 57(3):229-238.
[9] Aung W, Okauchi T, Sato M, et al. In-vivo PET imaging of inducible D2R reporter transgene expression using[11C]FLB 457 as reporter probe in living rats[J]. Nucl Med Commun, 2005, 26(3):259-268.
[10] Wester HJ, Schottelius M, Scheidhauer K, et al. PET imaging of somatostatin receptors:design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide[J]. Eur J Nucl Med Mol Imaging, 2003, 30(1):117-122.
[11] Ginj M, Chen J, Walter MA, et al. Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy[J]. Clin Cancer Res, 2005, 11(3):1136-1145.
[12] Anton M, Wagner B, Haubner R, et al. Use of the norepinephrine transporter as a reporter gene for non-invasive imaging of genetically modified cells[J]. J Gene Med, 2004, 6(1):119-126.
[13] Chung JK. Sodium iodide symporter:its role in nuclear medicine[J].J Nucl Med, 2002, 43(9):1188-1200.
[14] Shin JH, Chung JK, Kang JH, et al. Feasibility of sodium/iodide symporter gene as a new imaging reporter gene:comparison with HSV 1-tk[J]. Eur J Nucl Med Mol Imaging, 2004, 31(3):425-432.
[15] Niu G, Krager KJ, Graham MM, et al. Noninvasive radiological imaging of pulmonary gene transfer and expression using the human sodium iodide symporter[J]. Eur J Nucl Med Mol Imaging, 2005, 32(5):534-540.
[16] YaghoubiSS, WuL, LiangQ, etal. Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors[J]. GeneTher, 2001, 8(14):1072-1080.
[17] Ray P, Wu AM, Gambhir SS. Optical bioluminescence and positron emission tomography imaging of a novel fusion reporter gene in tumor xenografts of living mice[J]. Cancer Res, 2003, 63(6):1160-1165.
[18] Doübrovin M, Serganova I, Mayer-Kuckuk P, et al. Multimodality in vivo molecular-genetic imaging[J]. Bioconjug Chem, 2004, 15(6):1376-1388.
[19] Iyer M, Salazar FB, Lewis X, et al. Non-invasive imaging of a transgenic mouse model using a prostate-specific two-step transcriptional amplification strategy[J]. Transgenic Res, 2005, 14(1):47-55.